Nukkleus Inc. (NASDAQ:NUKK - Get Free Report) was the recipient of a significant increase in short interest in January. As of January 15th, there was short interest totalling 190,000 shares, an increase of 490.1% from the December 31st total of 32,200 shares. Based on an average daily trading volume, of 4,280,000 shares, the short-interest ratio is presently 0.0 days.
Nukkleus Stock Performance
NUKK stock traded down $1.35 during trading on Tuesday, hitting $27.32. The company had a trading volume of 243,049 shares, compared to its average volume of 1,814,938. The firm has a 50-day moving average price of $18.64 and a 200-day moving average price of $8.10. Nukkleus has a 12 month low of $1.30 and a 12 month high of $78.32.
Insider Buying and Selling at Nukkleus
In other Nukkleus news, CEO Anastasiia Kotaieva acquired 319,952 shares of the business's stock in a transaction on Friday, November 8th. The stock was purchased at an average price of $2.41 per share, for a total transaction of $771,084.32. Following the transaction, the chief executive officer now owns 319,952 shares in the company, valued at $771,084.32. This trade represents a ∞ increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 14.90% of the company's stock.
About Nukkleus
(
Get Free Report)
Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Nukkleus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nukkleus wasn't on the list.
While Nukkleus currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for February 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
